BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30153342)

  • 1. MERIT: Systematic Analysis and Characterization of Mutational Effect on RNA Interactome Topology.
    Li Y; McGrail DJ; Xu J; Li J; Liu NN; Sun M; Lin R; Pancsa R; Zhang J; Lee JS; Wang H; Mills GB; Li X; Yi S; Sahni N
    Hepatology; 2019 Aug; 70(2):532-546. PubMed ID: 30153342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of RNA binding protein interacting with circular RNA and hub candidate network for hepatocellular carcinoma.
    Cheng B; Tian J; Chen Y
    Aging (Albany NY); 2021 Jun; 13(12):16124-16143. PubMed ID: 34133325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human protein-RNA interaction network is highly stable across mammals.
    Ramakrishnan A; Janga SC
    BMC Genomics; 2019 Dec; 20(Suppl 12):1004. PubMed ID: 31888461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated bioinformatic analysis of RNA binding proteins in hepatocellular carcinoma.
    Wang L; Zhang Z; Li Y; Wan Y; Xing B
    Aging (Albany NY); 2020 Dec; 13(2):2480-2505. PubMed ID: 33411682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous Molecular-Cellular Network Cancer Theory: A Systems Biology Approach.
    Wang G; Yuan R; Zhu X; Ao P
    Methods Mol Biol; 2018; 1702():215-245. PubMed ID: 29119508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma.
    Li T; Li S; Chen D; Chen B; Yu T; Zhao F; Wang Q; Yao M; Huang S; Chen Z; He X
    Cancer Sci; 2017 May; 108(5):877-885. PubMed ID: 28231410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas.
    Seshachalam VP; Sekar K; Hui KM
    J Gastroenterol Hepatol; 2018 Dec; 33(12):2037-2047. PubMed ID: 29672926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and metastasis by stabilizing RORA mRNA.
    Han L; Huang C; Zhang S
    Liver Int; 2019 Nov; 39(11):2190-2203. PubMed ID: 31365778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
    J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the expression relationships between RNA-binding proteins and their cognate targets in eukaryotic post-transcriptional regulatory networks.
    Nishtala S; Neelamraju Y; Janga SC
    Sci Rep; 2016 May; 6():25711. PubMed ID: 27161996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational landscape of RNA-binding proteins in human cancers.
    Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
    RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell RNA binding protein regulatory network analyses reveal oncogenic HNRNPK-MYC signalling pathway in cancer.
    Zhou W; Jie Q; Pan T; Shi J; Jiang T; Zhang Y; Ding N; Xu J; Ma Y; Li Y
    Commun Biol; 2023 Jan; 6(1):82. PubMed ID: 36681772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.
    Caruso S; Calatayud AL; Pilet J; La Bella T; Rekik S; Imbeaud S; Letouzé E; Meunier L; Bayard Q; Rohr-Udilova N; Péneau C; Grasl-Kraupp B; de Koning L; Ouine B; Bioulac-Sage P; Couchy G; Calderaro J; Nault JC; Zucman-Rossi J; Rebouissou S
    Gastroenterology; 2019 Sep; 157(3):760-776. PubMed ID: 31063779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma by Integrated Microarray Analysis.
    Lin X; Chen Y
    Med Sci Monit Basic Res; 2018 Apr; 24():70-78. PubMed ID: 29706616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLIPdb: a CLIP-seq database for protein-RNA interactions.
    Yang YC; Di C; Hu B; Zhou M; Liu Y; Song N; Li Y; Umetsu J; Lu ZJ
    BMC Genomics; 2015 Feb; 16(1):51. PubMed ID: 25652745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the Role of RNA-Binding Proteins, with a Focus on RPS5, in the Malignant Progression of Hepatocellular Carcinoma.
    Zhou C; Wu Q; Zhao H; Xie R; He X; Gu H
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma.
    Xu W; Rao Q; An Y; Li M; Zhang Z
    PLoS One; 2018; 13(8):e0202763. PubMed ID: 30138346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer.
    He C; Huang F; Zhang K; Wei J; Hu K; Liang M
    J Ovarian Res; 2021 Feb; 14(1):27. PubMed ID: 33550985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.